Inova Dwight and Martha Schar Cancer Institute is First Cancer Center in the World to Achieve Four-year Accreditation for Radiation Oncology Services from ASTRO’s Accreditation Program for Excellence (APEx®)

inova logo

FALLS CHURCH, VA – December 21, 2015—Inova Dwight and Martha Schar Cancer Institute has demonstrated compliance with the standards of the American Society for Radiation Oncology (ASTRO) Accreditation Program for Excellence (APEx®), effective September 1, 2015, for a four-year accreditation of their radiation oncology services. They are the first Cancer Center in the world to…

Read More

Year in Review 2015: Inova’s $180 million bet on a ‘personalized health’ campus (Video), Washington Business Journal, December 17, 2015

For months, rumors had swirled that Inova Health System planned to buy Exxon Mobil’s 117-acre campus in Merrifield. That made it no less newsworthy in February when officials finally announced they’d closed a $180 million deal to acquire the site across the street from the health system’s flagship Fairfax Hospital. Read more. TweetPinShare0 Shares

Read More

Inova Dwight and Martha Schar Cancer Institute Names Leading Experts in Cancer Care, Research and Administration

inova logo

Inova Dwight and Martha Schar Cancer Institute (ISCI) names Jeanny Aragon-Ching, MD, Clinical Program Director of Genitourinary Cancers and (ISCI) names Thomas Graves, FACHE, Vice President for Cancer Services and ISCI Associate Director for Administration FALLS CHURCH, VA – October 28, 2015 – Inova today announced the addition of two leaders who will bring new…

Read More

The Future of Personalized Health at Inova

John Deeken, MD, is board certified in medical oncology. He specializes in treating patients with head and neck cancer. He is especially interested in using genomics to personalize cancer treatments and in developing targeted therapies. Dr. Deeken serves as associate director for Clinical Research for the Inova Dwight and Martha Schar Cancer Institute. In addition,…

Read More

Personalized medicine could mean big business for D.C.-area companies, The Washington Post, May 31, 2015

The American health-care industry’s pivot to personalized medicine has attracted the interest of an unlikely group of companies — government contractors. As health-care providers explore this new model of treatment, which involves the study of the human genome to provide personalized care, they face a problem with which many in government are familiar: analyzing an…

Read More

Inova Center for Personalized Health’s Cancer Program Receives $50 Million Gift

Donald (Skip) Trump, MD, named the Inova Dwight and Martha Schar Cancer Institute CEO & Executive Director FALLS CHURCH, VA. – Inova acknowledged today a $50 million gift from developer and philanthropist Dwight Schar launching the Inova Dwight and Martha Schar Cancer Institute. The center will anchor the new Inova Center for Personalized Health recently…

Read More